Preparation of All-Trans Retinoic Acid Nanosuspensions Using a Modified Precipitation Method
暂无分享,去创建一个
[1] B. C. Goswami,et al. Elevation of retinyl ester level in the lungs of rats following repeated intraperitoneal injections of retinoic acid or retinoyl glucuronide. , 2004, Pulmonary pharmacology & therapeutics.
[2] E. Avitabile,et al. Retinoids and Cancer: Antitumoral Effects of ATRA, 9-cis RA and the New Retinoid IIF on the HL-60 Leukemic Cell Line , 2003, Medical Principles and Practice.
[3] R. Müller,et al. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. , 2002, International journal of pharmaceutics.
[4] G. Bruni,et al. Thermoanalytical and spectroscopic characterisation of solid-state retinoic acid. , 2001, International journal of pharmaceutics.
[5] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[6] I. Uchegbu. Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs, Edited by R.H. Muller, S. Benita, B. Bohm, Medpharm Scientific Publishers, Stuttgart, 1998. ISBN 3-88763-069-6 , 2001 .
[7] M. Gabriëls,et al. Investigation of the chemical stability of an erythromycin-tretinoin lotion by the use of an optimization system. , 2000, International journal of pharmaceutics.
[8] R. Müller,et al. Nanosuspensions of poorly soluble drugs--reproducibility of small scale production. , 2000, International journal of pharmaceutics.
[9] Rainer H. Müller,et al. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .
[10] G. Liversidge,et al. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .
[11] G. Liversidge,et al. The surface modified drug nanoparticles , 1992 .
[12] Nick Hallas,et al. Crystallization and Precipitation , 1988 .